Ownership history in BARCLAYS PLC · 27 quarters on record
This page tracks every 13F SEC filing in which BARCLAYS PLC reported a position in ADAPTIMMUNE THERAPEUTICS PLC (ADAP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 2,527 | -7 | -0.3% | 0.00% | $66 | — |
| 2025 Q3 | ADDED | 2,534 | +7 | +0.3% | 0.00% | $330 | — |
| 2025 Q2 | REDUCED | 2,527 | -47,534 | -95.0% | 0.00% | $1K | — |
| 2025 Q1 | UNCHANGED | 50,061 | — | 0% | 0.00% | $10K | — |
| 2024 Q4 | UNCHANGED | 50,061 | — | 0% | 0.00% | $27K | — |
| 2024 Q3 | UNCHANGED | 50,061 | — | 0% | 0.00% | $48K | — |
| 2024 Q2 | UNCHANGED | 50,061 | — | 0% | 0.00% | $49K | — |
| 2024 Q1 | UNCHANGED | 50,061 | — | 0% | 0.00% | $79K | — |
| 2023 Q4 | UNCHANGED | 50,061 | — | 0% | 0.00% | $40K | — |
| 2023 Q3 | UNCHANGED | 50,061 | — | 0% | 0.00% | $39K | — |
As of 2025 Q4 — sorted by position size